| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |